Siemens resumes oncology shipments

Article

The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord,

The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord, CA,facility last year after FDA audits uncovered problems in manufacturingprocesses at the plant (SCAN 10/12/94).

Siemens received FDA approval on Nov. 2 to resume U.S. shipping,and got the agency's go-ahead in October to manufacture for U.S.customers. The facility has been shipping and manufacturing forinternational customers since March, the company reported. Theplant makes radiation oncology treatment and verification products.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.